ReviewThe international journal of neuropsychopharmacology2022

Suicide Biomarkers to Predict Risk, Classify Diagnostic Subtypes, and Identify Novel Therapeutic Targets: 5 Years of Promising Research.

Jenessa N Johnston et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.